Introduction to immune disease Flashcards

110 slides

1
Q

Where are different immune cells made in the body?

A

Stem cells in our bone marrow divide and differentiate into Myeloid progenitor cells and lymphoid progenitor cells.

  1. Lymphoid progenitor cells differentiate into:
    - Small lymphocytes -> B lymphocytes (plasma cells) and T lymphocytes
  • Natural killer cells
  1. Myeloid progenitor cells differentiate into:
    - Megakaryocytes -> Thrombocytes
    - Erythrocytes
    - Mast cells
    - Myeleoblast -> Basophils, neutrophils, eosinophil, monocytes (which become macrophages)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is autoimmunity? (ESSENTIAL)

A

It is an immune response against self (autologous) antigens.

Autoimmunity results from some failure of the hosts immune system to distinguish self from non-self.

  • Sufferers have high circulating levels of ‘auto-antibodies’ - hence antibodies that recognise self.
  • Autoimmune diseases are more frequent in women than men. May be due to the oestrogen levels in females that may influence immune system to predispose to autoimmune diseases.
  • The presence of one autoimmune disease increases chance for developing another simultaneous autoimmune disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is an immunogen?

A

A substance capable of eliciting/causing an immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a Tolerogen?

A

Antigens that induce tolerance rather than immune reactivity.

Meaning our immune system can identify them but it doesn’t mount an immune response against them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Can the same compound be an immunogen and tolerogen?

A

Yes, but it depends on how and where it is presented to the immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do we achieve self tolerance?

A
  1. Segregation of antigens

This is achieved by physical barriers and immune privileged sites like for example the eyes.
- Our eyes are in an immune privileged site so cells of our immune system, so our B and T cells can’t ever get there so therefore it doesn’t matter what antigens we have in the eyes because it will never be exposed to the immune system.

  1. Central tolerance
    Limits the development of auto reactive B and T cells
  2. Peripheral tolerance:
    Regulates auto reactive cells in the circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why do we have both central and peripheral tolerance?

A
  • Not all self antigens are expressed in the central lymphoid organs where negative selection occurs
  • There is a threshold requirement for affinity to self antigens before deletion is triggered- some weakly self reactive antigens survive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to T cells in the central tolerance? (ESSENTIAL)

A
  • We have the immature T lymphocytes in the thymus and they’re exposed to self-antigens during development.
  • They are exposed to these self- antigens via the antigens presenting cells (APC).
  • The APC is presenting them via the MHC complex to the self-antigens.
  • CD4 or CD8 receptors also play a role here
  • This interaction leads to different kinds of reactions from the cell:

STRONG INTERACTION: It will undergo negative selection and undergo apoptosis.

WEAK INTERACTION: We take it for positive selection

NO INTERACTION / NOT RECOGNISED: Undergoes apoptosis

INTERMEDIATE INTERACTION: Might become a regulatory T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do T regulatory cells do?

A

It governs how our T cells will actually react.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens to B lymphocytes in the central tolerance? (ESSENTIAL)

A
  • Immature B lymphocytes will mature in the bone marrow and they become exposed to self antigens during development.
  • We have the B cell with a B cell receptor and the self antigen will bind to the B cell receptors
  • There will be different interactions depending on how the IgE antibody on the B cell reacts to the self antigen:

HIGH AVIDITY:
- Cell might undergo RECEPTOR EDITING and express a new light chain and this new light chain will bind to the self antigen with high avidity, then we get rid of the B cell and it undergoes apoptosis.

LOW AVIDITY:
- Reduces receptor expression and the cell becomes anergic. Meaning the B cell will never react towards this self antigen ever again.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does anergic mean and why is it preferred in central tolerance of B cells?

A

Anergy or to be anergic is a condition in which the body immune system fails to react to an antigen. This is needed hence low avidity reaction is preferred as we don’t want an immune response to self-antigens if not it’ll lead to an autoimmune disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What happens in the peripheral tolerance of T lymphocytes? (ESSENTIAL)

A
  1. T cell Normal Response (non-self antigen)
  • In normal response the T cells become exposed to an antigen and become activated. Co-stimulation occurs
  • Resulting in: Effector T cells and Memory T cells.
  1. Response to self antigen
  • T cell exposed to self-antigen
  • T regulatory cells come along and ensure the T cell doesn’t become activated.
  • This can then lead to 3 conclusions:

ANERGIC: Hence functionally unresponsive, without the necessary costimulatory signals

SUPPRESSION: The regulatory T cell will suppress/block the activation

DELETION: If it still becomes activated, the T cell will be killed off - apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens in the peripheral tolerance of B lymphocytes? (ESSENTIAL)

A
  1. B cell Normal response (non-self antigen)
  • Our B cells are exposed to non-self antigens and they become activated.
  • The helper T cells are releasing cytokines which will help the activation of T cells
  • Results in the production of plasma cells and produce antibodies.
  1. Response to self antigen
  • Self antigen binds to the B cell receptor.
  • There’s no T cell activation hence no helper T cells releasing any cytokines.
  • Without the help of T cells, the B cells can result in 3 conclusions:

ANERGIC: Functionally unresponsive

APOPTOSIS: Killed off

INHIBITORY RECEPTORS: Can be prevented from becoming activated by inhibitory receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is required in order to have B cell activation? (ESSENTIAL)

A

Activation of T cells

  • Maintaining T cell tolerance enforces B cell tolerance to the same antigens.
  • WE ONLY GET B CELLS ACTIVATED TOWARDS A SELF ANTIGEN IF YOU ALREADY HAVE A T CELL ACTIVATION TO THE SAME SELF-ANTIGEN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of action of cytokine deviation in terms of self tolerance? (ESSENTIAL)

A

There is differentiation to the Th2 cells hence limiting the inflammatory cytokine secretion hence no immune response activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action of clonal deletion in terms of self tolerance? (ESSENTIAL)

A

Where apoptosis occurs post activation. So even after activation occurs it can be killed off by clonal deletion hence stopping the immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

So when does autoimmune disease occur? (ESSENTIAL)

A

Although we have central and peripheral tolerance, autoimmune disease happens when the tolerance actually fails (multiple layers of self tolerance become dysfunctional).

  • May be due to having the wrong genes or wrong environment and when these 2 factors come together (combination) we usually end up with autoimmune disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What may occur to break/fail the self tolerance? (ESSENTIAL)

A
  • There are susceptibility genes present and they might lead to the production of self reactive lymphocytes causing self-tolerance to fail.
  • At the same time if you have an infection or inflammation occurring, that might mean we have activation of tissue antigen presenting cells (APCs) and at the same time we may get an influx of self-reactive lymphocytes into the tissues.
  • When these 2 things come together, it might lead to the activation of self-reactive lymphocytes.
  • Hence leading to TISSUE INJURY -> Autoimmune disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do genes play a role in autoimmune diseases? (ESSENTIAL)

A
  • There is a genetic predisposition of autoimmune disease, and research shows high incidence in twins (more in monozygotic twins (identical) than in dizygotic twins (non-identical)).

-Most autoimmune diseases are polygenic and affected individual multiple genetic polymorphism (so not only one gene determining immune disease but usually a whole cluster of different genes) that contribute to disease susceptibility.

  • There is a strong association of MHC Class 2 genes with disease.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What role do infections play in autoimmunity? (ESSENTIAL)

A

Infections can trigger autoimmune reactions.

  • Autoimmunity may develop after infection if done/finished. Meaning the autoimmune disease is triggered by the infection but is not directly caused by the infection.
  • Some autoimmune diseases are prevented by infections. Mechanism is unknown but similar to the “hygiene hypothesis” -> If we are exposed to more antigens/infections, our body is better capable of differentiating between self and non-self.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the different mechanisms of autoimmune damage? (ESSENTIAL)

A
  1. Circulating autoantibodies
  • There are circulating autoantibodies that can do anything such as compliment lysis, interacting with cell receptors, formation of toxic immune complexes, antibody dependent cellular cytotoxicity and even penetration into living cells.
  1. T Lymphocytes
  • CD4 cells polarised towards Th1 responses via cytokines which can drive the inflammatory response.
  • CD8 cells activated to become cytotoxic T cells and cause direct cytolysis (Burst due to osmotic imbalance)
  1. Non-specific mechanisms
  • Recruitment of inflammatory leucocytes into autoimmune lesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are some common autoimmune diseases?

A

Systemic autoimmune diseases:
- Rheumatoid arthritis

Organ specific autoimmune diseases:
- Myasthenia gravis
- Grave’s disease
- Autoimmune diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is organ-specific autoimmunity? (ESSENTIAL)

A
  • Autoantibodies are made against nicotinic acetylcholine receptors
  • The antibodies work by mimicking a ligand which causes the continuous stimulation of the thyroid cells
  • Cause of disease is unknown, maybe viral infections are involved in triggering this immune response.
  • Autoantigens have been implicated, including glutamic acid decarboxylase (GAD) and insulin itself.
  • Ion channel which functions as a receptor in muscles, receives input from motor neurone at the neuromuscular synapse and induces muscle contraction.
  • Autoantibodies are directed against the receptor for thyroid-stimulating hormone (TSH)
  • Autoantibodies prevent binding of acetylcholine to the receptor and include internalisation and degradation of the receptor.
  • Cell mediated attack on the islets of Langerhans in the endocrine pancreas results in the death of the insulin-producing beta-cells
  • Causes severe muscle weakness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Which sites in the body are immunologically privileged?

A
  • Brain
  • Eyes
  • Testis
  • Uterus (fetus)
  • Hamster cheek pouch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What conventional therapies available for autoimmune diseases?

A

As most of the time, we have an inflammatory disease underlying the autoimmune disease, we can use:

  1. Anti-inflammatory drugs
    - Aspirin, ibuprofen
    - Corticosteroids (can block TNF and IL-1 production)

We can also use:

  1. Immunosuppressive drugs
    - For inhibition of lymphocyte proliferation
    - E.g. Ciclosporin A
  2. Non-specific control of autoantibodies in the blood
    - IV immunoglobulin (IV-IG): antibodies of multiple specificity from a group of healthy donors. Mechanism of action unsure.
    - Plasmapheresis (removal of circulating antibodies from the bloodstream, short term)
  3. Organ specific
    - Insulin to treat diabetes
    - Acetylcholinesterase inhibitors in Myasthenia Gravis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is happening overall in inflammation?

A

There is an invasion of bacterium, through the epithelial cell layer (can occur elsewhere) and the bacterium will be recognised by mast cells or macrophages in our skin. These cells will then start to release different types of mediators:

  1. lipid mediators:
    Prostaglandins
    Leukotrienes
    Platelet-activating factor
  2. Chemokines
  3. Cytokines:
    TNF
    IL-1
    IL-6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What happens in inflammation (step by step) when macrophages release cytokines to result in a fever?

A
  1. Macrophage engulfs a gram-negative bacterium via endocytosis.
  2. The bacterium contains endotoxins and the endotoxins are released and will activate the macrophage to release IL-1.
  3. IL-1 is released and get into the blood vessels and travels to the hypothalamus of the brain.
  4. In the hypothalamus, IL-1 induces the production of prostaglandins. Prostaglandins will the RESET your body “thermostat” to a higher temperature, resulting in a fever.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are main symptoms of inflammation?

A
  1. Rubor - Redness (blood rushing to the area)
  2. Dolour - Pain
  3. Calor - Heat, fever
  4. Tumour - Swelling (fluid leakage)
  5. Function laesa - loss of function (severe cases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What causes an inflammation?

A

Inflammation is a response to cellular insults which may be caused by infectious agents, toxins or physical stresses.

Inflammation is a protective response from our body, the ultimate goal being to remove the initial cause of injury and consequences of injury such as the necrotic cells and tissues hence to protect our body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the step-by-step process that occurs during an inflammatory response? (ESSENTIAL)

A
  1. Insult by trauma or pathogen causing release of cytokine and acute phase reaction occurs. Where TNFa, IL-1 and IL-6 is released.
  2. Platelet adhesion, transient vasoconstriction of efferent vessels
  3. Cytokine-induced vasodilation of afferent vessels (increased heat and blood flow to the area). Vasodilation and increased vascular permeability, hence more blood rushing to the site of inflammation, which causes the redness, heat and swelling.
  4. Activation of complement system, coagulation, fibrinolytic and kinin systems
  5. Leukocyte adhesion
  6. Increase vascular permeability and extravasation of serum proteins (exudate) and leukocytes (-> neutrophils -> macrophages -> lymphocytes) which results in tissue swelling. Inflammatory cells migrate into tissues, releasing inflammatory mediators (NK cells and macrophages) causing pain. These inflammatory mediators attract more and more cells to the site of inflammation.
  7. Phagocytosis of forge in material with pus formation
  8. Wound healing and remodelling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

How do cells migrate through to the endothelial cell layer?

A

Our leukocytes and neutrophils are floating in our blood vessels at quite a high speed.

If there is a site of inflammation, that means we release cytokines and chemokines/chemoattractants.

These chemoattractants are displayed on the endothelial cell surface, inside the blood vessel. So when the neutrophils float around here, they are captured by the chemoattractants, they start to slow down, they start to roll over the endothelial cell layer and then they finally firmly adhere to the endothelial cell layer. Once adhered they can transmigrate through the endothelial cell layer to the site of inflammation and can eat up bacteria at the site and help with the resolution of the inflammatory response.

32
Q

What happens during the vasodilation stage of inflammation? (ESSENTIAL)

A

During vasodilation you produce histamines, kinin, prostaglandin and leukotrienes.

33
Q

What happens during the migration and margination stages of inflammation? (ESSENTIAL)

A

Cells are binding to the blood vessels and migrating into the tissue.

34
Q

What does the term Diapedesis mean?

A

Diapedesis is when the phagocytes force themselves between the endothelium cells of the blood vessel and migrate into the tissue.

35
Q

What do pro-inflammatory mediators do and name a few. (ESSENTIAL)

A

Pro-inflammatory mediators will be released and will drive the inflammation. They include the:
- Acute phase proteins
- Complement system where we produce C3a and C5a.
- Kinins (e.g. bradykinins)
- Cytokines:
Pro-inflammatory (TNF, IL-1, IL-6 etc), Chemokines (attractants), Growth factors
- Adhesion molecules - VCAM-1 , ICAM- 1
- Metric Metalloproteinases - MMPs
- Clotting factors
- Prostaglandins

36
Q

How are cytokines involved in promoting inflammation?

A
  • Cytokines activate immune cells and other cells in the local environment. They’re there to help get the immune cells to the site of inflammation and activate them.
  • They recruit immune cells to the environment to attack the offending pathogen/toxin
  • The growth factors stimulate immune and non-immune cell growth.
  • Cytokines also act as endogenous pyrogens, which means they will drive the immune response and are capable of changing the overall temperature of your body.
  • Cytokines induce acute phase proteins in the liver.
37
Q

What are acute phase proteins and name some examples. (ESSENTIAL)

A

Acute phase proteins (APPs) are usually made by hepatocytes.

They are synthesised in response to pro-inflammatory cytokines and include:

  1. C Reactive Proteins -> It is an opsonin (labels cells to ensure they are taken up by phagocytosis)
  2. Fibrinogen -> Coagulation factor
  3. Serum Amyloid A -> Aids cell recruitment and MMP inducer
  4. Complement factors -> Opsonin, Lysis, Clumping and Chemotaxis
  5. Haptoglobin and ferritin -> Bind to haemoglobin or Fe
38
Q

What is the function of Interleukin-1 (IL-1)? (ESSENTIAL)

A

IL-1 drives inflammation, can induce fever and induces APP in the liver.

39
Q

What is the function of Tumour necrosis factor alpha (TNFa)? (ESSENTIAL)

A

TNFa induces APP in the liver, leads to inflammation, induction of cell death and neutrophil activation.

40
Q

What is the function of Interleukin 12 (IL-12)? (ESSENTIAL)

A

Activates Natural Killer cells and promotes Th1

41
Q

What is the function of Interleukin 6 (IL-6)? (ESSENTIAL)

A

Induces APP in the liver and influences adaptive immunity by inducing proliferation and antibody secretion by B cells.

42
Q

What is the function of Interferon alpha and beta (IFNa/b)? (ESSENTIAL)

A

Induces antiviral state and activates natural killer cells.

43
Q

What are chemokines?

A

Chemokines are chemotactic meaning they can attract cells.

There are 4 different families of chemokines:
CC, CXC, C, CXXXC, which bind to G-protein coupled receptors

Chemokines can act on different immune cell types e.g:
- Interleukin 8 attracts neutrophils - ESSENTIAL
- Monocyte chemotactic protein 1 attracts monocytes - ESSENTIAL
- Eotaxin attracts eosinophils etc.

44
Q

What are adhesion molecules? (ESSENTIAL)

A

They are transmembrane receptors that bind either to other cells or to the extracellular matrix. These allow the leukocytes to attack themselves to the endothelial cell layer.

There are 4 main classes:
1. Ig superfamily e.g. VCAM-1, ICAM-1, LFA-2

  1. Cadherins e.g. E, P, N (cell-cell adhesion)
  2. Selectins - E,P,L - recognise carbohydrates
  3. Integrins- 8 subfamilie, e.g. a4B1 (ECM and cell-cell)

All these adhesion molecules make possible for the cells to interact with each other and the extracellular matrix to interact with these cells.

45
Q

How are metalloproteinases involved in inflammation? (ESSENTIAL)

A
  • Metalloproteinases are proteases whose catalytic function required metal, usually zinc.
  1. Matrix metalloproteinases (MMPs):
    - Degrade and remodel extracellular matrix
    - They create chemokine gradients
  2. ADAMs
    - Cleave cytokine and adhesion molecule receptors from cell surfaces
  3. ADAMTs
    - They also cleave receptors
    - Degrades proteoglycans
46
Q

What are the extracellular matrix proteins (ECM)? (ESSENTIAL)

A
  1. Collagen type I, II and III - which are fibrillar found in bone, skin and cartilage
  2. Collagen type IV- basement membrane
  3. Laminin, Elastin, Proteoglycans, Aggrecan, Fibronectin, Matrilin, Nidogen

These are really important in providing a layer on top of the cells and allowing cells to interact with each other.

47
Q

What are NF-kB? (ESSENTIAL)

A

NF-kB is a family of transcription factors that regulate pro-inflammatory mediators. They help with the production of:
- Cytokines
- Chemokines and their receptors
- Adhesion molecules
- MMPs
- Growth factors
- Acute phase proteins

NF-kB is really important, without NF-kB, we won’t get the production of these pro-inflammatory mediators.

48
Q

How does NF-kB become activated? (ESSENTIAL)

A

In a normal cell, NF-kB is bound to a protein called Ik-B which is an inhibitor of kB.

If you have DNA-damaging agents, bacterial infection, viruses or pro-inflammatory cytokines, we get proteins activated inside the cell like Ik-B kinase. Ik-B kinase will phosphorylate Ik-B. Once phosphorylated, Ik-B will be degraded and broken down in smaller molecules which ultimately releases NFk-B.

When NFk-B is released, it can migrate into the nucleus. In the nucleus NFk-B binds onto promoter sequences and will drive the transcription of certain pro-inflammatory cytokines etc.

49
Q

What is the final stage of inflammation after phagocytes have been attracted to the site of inflammation via chemokines and chemotaxis? (ESSENTIAL)

A

The attracted phagocytes destroy microorganisms and any mutated or dead cells.

Then finally tissue repair occurs, where dead and damaged cells are rebuilt and the whole system goes back to basil (normal).

50
Q

What is the aim of the resolution phase of the inflammatory response?

A

To calm down the inflammation and go back to the physiological state. This is done by anti-inflammatory mediators by counteracting the pro-inflammatory mediators.

51
Q

What is the difference between anti-inflammatory mediators and pro-inflammatory mediators?

A
  • Its in the names*
  • Pro-inflammatory mediators drive the inflammatory response
  • Anti-inflammatory mediators calm down the inflammatory response with an aim to go back to the normal physiological state.
52
Q

Name the anti-inflammatory mediators. (ESSENTIAL)

A
  • Anti-inflammatory cytokines -IL10 etc
  • Soluble adhesion molecules
  • TIMPs- proteins that inhibits MMPs
  • Plasmin activation system- clot recedes (lessens)
  • Opioid peptides - counteracts pain
  • Resolvins / Protectins - anti-inflammatory lipid mediators
53
Q

What is acute inflammation? (ESSENTIAL)

A
  • Acute inflammation is a necessary part of immune response
  • If it is excessive it can lead to organ failure and death

ACUTE INFLAMMATION INCLUDES RESOLUTION -> WHERE WE GO BACK TO NORMAL PHYSIOLOGY.

54
Q

What is chronic inflammation? (ESSENTIAL)

A
  • It is an inappropriate form of inflammation including tissue destruction
  • It leads to diseases such as autoimmune, neurodegenerative and chronic age-related disorders etc.
55
Q

What happens if we don’t get back to normal physiology and resolution is not achieved? (ESSENTIAL)

A

It results in ongoing acute inflammation. We keep releasing cytokines, chemokines, MMPs etc (pro-inflammatory mediators) and we keep driving this inflammation not reaching normal physiology.

This chronic inflammation leads to abscess formation (pus), excess scarring and autoimmunity.

56
Q

What are the current and novel anti-inflammatory therapies available?

A
  1. Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
  2. Steroids
  3. Immunosuppressive agents
  4. Other Novel therapies:
    - Anti-cytokine - TNF antibodies
    - Anti-adhesion molecules
    - MMP inhibitors
    - Other small molecules
57
Q

What are DMARDs? (ESSENTIAL)

A
  • DMARDs stands for Disease-Modifying anti rheumatic drugs
  • DMARDs aim to halt or reverse the underlying disease itself.
  • Examples include Methotrexate, sulfasalazine etc.
58
Q

What is methotrexate? (ESSENTIAL)

A
  • Methotrexate is a folic acid antagonist with cytotoxic and immunosuppressant activity, meaning it can kill cells but also suppress your immune response.
  • Obtains useful and reliable anti rheumatoid action and common first-choice drug in rheumatoid arthritis.
  • Methotrexate, compared to other DMARDs, has a rapid onset of action hence why the treatment must be closely monitored as bone marrow depression can occur which causes a drop in WBC and platelet counts (potentially fatal) and liver cirrhosis.
59
Q

Why is methotrexate more superior compared to other DMARDs? (ESSENTIAL)

A

Methotrexate is superior to most other DMARDs due to efficacy and patient tolerance. It is often given in conjunction with anticytokine drugs.

60
Q

What action does Methotrexate have on folic acid?

A
  • Folates are essential for the synthesis of purine nucleotides and thymidylate, which in turn are essential for DNA synthesis and cell division*
  • The main action of folate antagonists (e.g. methotrexate) is to interfere with thymidylate synthesis. It blocks the dihydrofolate reductase hence preventing nucleotide production.
  • Methotrexate is usually given orally but can also be given intramuscularly, intravenously or intrathecally.
  • It has a low lipid solubility and thus does not readily cross the blood-brain barrier
  • However methotrexate is readily taken up into cells by the folate transport system and is metabolised to polyglutamate derivatives, which are retained in the cell for weeks or months even in the absence of extracellular drug.
61
Q

What is Ciclosporin? (ESSENTIAL)

A
  • It is a fungal metabolite
  • The structure of Ciclosporin does not obey Lipinski’s rules - it is way too big
  • However orally bioavailable as balance of hydrophilicity and hydrophobicity is sufficient to cross gut membrane.
  • Main metabolism of ciclosporin is through P450 enzyme leading to drug interactions.
62
Q

What is the mechanism of action of Ciclosporin in terms of immunosuppression? (ESSENTIAL)

A
  • Ciclosporin has potent immunosuppressive activity but no effect on the acute inflammatory reaction.
  • It does not entail cytotoxicity (hence does not kill off cells)
  • Ciclosporin causes decreased clonal proliferation of T cells, primarily by inhibiting IL-2 synthesis and possibly also by decreasing expression of IL-2 receptors
  • Reduced induction and clonal proliferation of cytotoxic T cells from CD8+ precursor T cells
  • Reduced function of the effector T cells responsible for cell-mediated response (e.g. decreased delayed-type hypersensitivity)
  • Some reduction of T cell-dependant B-cell response
63
Q

How can Ciclosporin be given and what are some potential side effects?

A
  • Ciclosporin itself is poorly absorbed by mouth but can be given orally in a more readily absorbed formulation, or by IV
  • After oral administration, peak plasma concentrations are usually achieved in about 3-4 hours. The plasma half-life is approximately 24 hours.
  • Ciclosporin accumulates in most tissues at concentrations 3-4 times than seen in the plasma.
  • Some of the drug remains in the lymphomyeloid tissue and remains in fat depots for some time after administrations stopped.
  • Most common and serious side effect of Ciclosporin is nephrotoxicity, which is thought to be unconnected with calcineurin inhibition.
  • Hepatotoxicty and hypertension can also occur
64
Q

What is Leflunomide? (ESSENTIAL)

A
  • Leflunomide is mainly used to treat RA and occasionally to prevent transplant rejection.
  • It has a relatively specific inhibitory effect on activated T cells. It is transformed to a metabolite that inhibits de novo synthesis of pyrimidines by inhibiting dihydro-orotate dehydrogenase.
  • It is orally active and well absorbed from the GI tract. It has a long plasma half-life, and the active metabolite undergoes enterohepatic circulation.
  • Side effects: Diarrhoea, alopecia (hair loss), raised liver enzymes and a risk of hepatic failure
  • The long half-life increases the risk of cumulative toxicity
65
Q

What are anti-inflammatory drugs?

A

Anti-inflammatory drugs inhibit the cycle-oxygenase (COX) enzyme:
- NSAIDs
- Coxibs

  • We also have antirheumatic drugs- DMARDs - together with some immunosuppressants they also have an anti-inflammatory effect
  • The glucocorticoid steroids
  • Anticytokines and other biopharmaceutical agents
  • Antihistamines used for the treatment of allergic inflammation
  • Drugs specifically used to control gout
66
Q

What are NSAIDs?

A
  • Stands for Non-steroidal anti inflammatory drugs
  • They provide symptomatic relief from fever, pain, swelling in chronic joint diseases as well as in acute inflammatory conditions
  • Also useful in treating post-operative, dental and menstrual pain as well as headaches and migraines
67
Q

What is the mechanism of action of NSAIDs? (ESSENTIAL)

A
  • The NSAIDs act and work on the fatty acid cycle-oxygenase, COX enzyme.
  • In the body theres 2 main isomers of the COX enzyme, COX 1 and COX 2
  • They are highly homologous enzymes but are regulated in different and tissue-specific ways
  • They enzymatically combine arachidonic acid and some other unsaturated fatty acid substrates with molecular oxygen to form unstable intermediates, cyclic endoperoxides, which cane be transformed by other enzymes to different prostanoids.
68
Q

What are lipoxygenases? (ESSENTIAL)

A

Lipoxygenases exist in several subtypes which often work sequentially to synthesise leukotrienes, lipoxins and other compounds

69
Q

How is COX involved in the production of inflammatory mediators?

A
  1. When there is a stimulus (e.g. injury) , phosolipase A2 becomes activated.
  2. Phospholipase A2 converts phospholipids into arachidonic acid.
  3. The COX enzymes then transform the arachidonic acid into either prostaglandins
  4. Lipoxygenases transform the arachidonic acid into leukotrienes.
70
Q

What is the difference between COX 1 and COX 2?

A
  • COX 1 is present in most cells and it produces prostanoids that act mainly as homeostatic regulators.
  • Whereas COX 2 is not normally present but is strongly induced by inflammatory stimuli hence more relevant as a target for anti-inflammatory drugs
71
Q

How are prostaglandins produced? (ESSENTIAL)

A
  1. Arachidonic acid is transformed by the COX enzymes into prostaglandin, prostacyclin and thromboxane.
  2. COX 2 is induced by inflammation therefore the prostaglandin, prostacyclin and thromboxane produced are really important for inflammation, fever and pain.
  3. The prostaglandins proceeds by COX 1 all have different functions in the body not leading to inflammation
  4. Both of these enzymes can be inhibited by aspirin and ibuprofen (NSAIDs)
72
Q

Which prostaglandins are important in the inflammatory response? (ESSENTIAL)

A
  • PGE2 predominates, although PGI2 is also important

Acute Inflammation: PGE2 and PGI2 are made by the local tissues and blood vessels, while mast cells release mainly PGD2

Chronic Inflammation: Cells of the macrophage series also release PGE2 and TXA2. They both have a yin-yang effect in inflammation, by stimulating some responses and decreasing others.

  • The anti-inflammatory and analgesic effects of NSAIDs come from their ability to block these actions/prostanoids
73
Q

What are the therapeutic effects of COX inhibitors? (ESSENTIAL)

A

COX inhibitors inhibit COX enzymes and therefore prostanoid synthesis, in inflammatory cells.

Inhibiting COX 2 (crucial) results in:

  1. An anti-inflammatory action:
    - Decrease in prostaglandin E2 and prostacyclin reduces vasodilation and indirectly oedema.
  2. An analgesic effect:
    - Decreased prostaglandin production means less sensitisation of nociceptive nerve endings to inflammatory mediators such as bradykinin. Relief of headache is probably a result of decreased prostaglandin-mediated vasodilation.
  3. An antipyretic effect:
    - Interleukin 1 releases prostaglandins in the central nervous system, where they elevate the hypothalamic set point for temperature control, thus causing fever. NSAIDs prevent this therefore preventing fever.
74
Q

What are the side effects of COX inhibitors?

A

Most of these occur as COX 1 is also being inhibited at the same time and COX 1 is an important housekeeping enzyme (homeostatic regulators).

  • Dyspepsia (indigestion), nausea, vomiting and other GI effects
  • Adverse cardiovascular effects
  • Skin reactions
  • Reversible renal insufficiency
  • Bronchospasm
  • Analgesic-associated nephropathy
  • Liver disorders, bone marrow depression
75
Q

What are the clinical uses of NSAIDs? (ESSENTIAL)

A
  1. Antithrombotic e.g. aspirin (other NSAIDs increase risk of thrombosis and should be avoided) for patients at high risk of arterial thrombosis
  2. Analgesia (pain relief)
  3. Anti-inflammatory
  4. Antipyretic (to reduce/prevent fever)
76
Q

What is aspirin?

A
  • Aspirin is a NSAID and it acts by irreversibly inactivating COX 1 and
  • In addition to its anti-inflammatory actions, aspirin also strongly inhibits platelet aggregation (used in CVD)
  • Given orally and rapidly absorbed. 75% metabolised in the liver

SIDE EFFECTS:
1. Therapeutic doses: GI symptoms

  1. Larger doses: Dizziness, deafness and tinnitus
  2. Toxic doses (e.g. self poisoning): uncompensated metabolic acidosis (too much acid in body fluids), particularly in children
  3. Aspirin is linked with Reyes syndrome in children so not used for paediatric purposes
    1. If given with Warfarin, aspirin can cause an increase in the risk of bleeding *
77
Q

What is paracetamol?

A
  • Paracetamol has potent analgesic and antipyretic actions but much weaker anti-inflammatory effects than other NSAIDs.
  • Its COX inhibitory action seems to be restricted to the CNS enzyme.
  • Given orally and metabolised in the liver (half life about 2-4 hours)
  • Toxic doses of paracetamol can cause nausea and vomiting, then, after 24-48 hours, potentially fatal liver damage by saturating normal conjugating enzymes, causing the drug to be converted by mixed function oxidases to N-acetyl-pbenzoquinone imine. If not inactivated by conjugation with glutathione, this compound reacts with cellular proteins causing TISSUE DAMAGE. *
  • Agents that increase glutathione can prevent liver damage if given early